DNBSEQ-T7RS HotMPS High-throughput Sequencing Set* is specifically designed for DNA or RNA sequencing on DNBSEQ-T7RS**. This sequencing set is intended to be used for scientific research only and cannot be used for clinical diagnosis.
|
940-000405-00 |
DNBSEQ-T7RS Sequencing Flow Cell V2.0 |
| 940-000551-00 |
DNBSEQ DNB High-efficiency Make Reagent Kit |
| 1000028451 |
DNBSEQ-T7RS DNB Rapid Load Reagent Kit V2.0 |
|
940-000255-00 |
DNBSEQ-T7RS HotMPS High-throughput Sequencing Kit |
|
940-000258-00 |
DNBSEQ-T7RS Cleaning Reagent Kit |
 High-speed 20-22 HOURS for PE100 sequencing |  High-flexibility 4 Flow Cells, PE100 at the same time |
 Ultra-high Throughput Up to 4 Tb/DAY, High quality data 24/7 |
|
Squencing type |
Application |
|---|---|
|
PE100 |
WES/WGS/RNA-seq/Multiple PCR |
|
Read length |
PE100 |
|
Maximum cycles |
220 |
|
Effective reads/flow cell (1) |
5000M |
| Data output (2) | 1~4Tb |
| Q30 (1) | >85% |
| Run time (3) |
20-22hrs |
|
(1) Effective reads and Q30 are based on the standard library. These values may vary depending on various applications. (2) Data output includes the output of 1-4 flow cells running at the same time. (3) Run time includes DNB loading, sequencing, and data process (Fastq writing). Run time may vary with various instruments. |
*This sequencing reagent is only available in selected countries.
** This sequencer is only available in selected countries, and its software has been specially configured to be used in conjunction with MGI’s HotMPS sequencing reagents exclusively.
The HotMPS sequencing reagent can only be used with DNBSEQ-T7RS (Cat.No.900-000599-00) whose software has been configured for HotMPS, and will not work effectively with MGI’s sequencer whose software has not been properly configured for HotMPS. Use of these reagents with sequencers whose software has not been configured for HotMPS will invalidate any warranty which may have been provided by MGI, and any liability for intellectual property infringement arising from the use of such reagents is excluded from any IP indemnity.
Subscribe Newsletter
